Clinical trial
Effect of Direct Acting Antiviral Agents on Behavior of Hepatocellular Carcinoma and Overall Survival in Patients With Chronic Hepatitis C
NCT03200171 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Direct Acting Antiviral Agents on Behavior of Hepatocellular Carcinoma and Overall Survival in Patients With Chronic Hepatitis C
- Lead sponsor
- Al-Azhar University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 10, 2018
- Completion date
- July 19, 2021
- Enrollment
- 300 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.